Impairment of innate cellular response to in vitro stimuli in patients on continuous ambulatory peritoneal dialysis

Nephrology Dialysis Transplantation

Volumn 20, Issue 11, 2005, Pages 2497-2503

  Ando, Minoru ^a   Shibuya, Asuka ^a   Yasuda, Masako ^b   Azuma, Naoko ^b   Tsuchiya, Ken ^b   Akiba, Takashi ^b   Nitta, Kousaku ^b  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Helper T cell; IL 1 ; Intracellular cytokine; Monocyte; TNF

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MITOGENIC AGENT; MONOKINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBODY LABELING; ARTICLE; CELL LABELING; CELLULAR IMMUNITY; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HELPER CELL; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; IN VITRO STUDY; INFECTION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; MALE; MONOCYTE; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

BIOLOGICAL MARKERS; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-4; INTRACELLULAR FLUID; KIDNEY FAILURE, CHRONIC; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PHENOTYPE; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 27644468659     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi048     Document Type: Article

References (18)

1. United States Renal Data System. Outcomes. Hospitalization and Mortality. In: USRDS 2003 Annual RepoHt. Downloaded from: http://www.usrds.org
2. Patient Registration Committee, Japan Society for Dialysis Therapy. An overview of dialysis treatment in Japan. J Jpn Soc Dial Ther 2001; 34: 1121-1147
3. Girndt M, Sester M, Sester U, Kaul H, Kohler H. Molecular aspects of T- and B-cell function in uremia. Kidney Int 2001; 59 [Suppl 78]: S206-S211
4. Decamps-Latscha B, Jungers P. New molecular aspects of chronic uraemia and dialysis-related immunocompetent cell activation. Nephrol Dial Transplant 1996; 11 [Suppl 2]: S121-S124
5. Netea M, van der Meer JM, van Deuren M, Kullberg BJ. Proinflammatory cytokines and sepsis syndrome: Not enough, or too much of a good thing? Trends Immunol 2003; 24: 254-258
6. Medzhitov R, Janeway C, Jr. Innate immunity. N Engl J Med 2000; 343: 338-344
7. Strieter RM, Belperio JA, Keane MP. Cytokines in innate host defense in the lung. J Clin Invest 2002; 109: 699-705
8. Betz M, Haensch GM, Rauterberg EW, Bommer J, Ritz E. Cuprammonium membranes stimulate interleukin-1 release and arachidonic acid metabolism monocytes in the absence of complement. Kidney Int 1988; 34: 67-73
9. Lonnemann G, Barndt I, Kaever V et al. Impaired endotoxin-induced interleukin-1β secretion, not total production, of mononuclear cells from ESRD patients. Kidney Int 1995; 47: 1158-1167
10. Grooteman MPC, Nube MJ, Daha MR et al. Cytokine profiles during clinical high-flux dialysis: No evidence for cytokine generation by circulating monocytes. J Am Soc Nephrol 1997; 8: 1745-1754
11. Picker LJ, Singh MK, Zdraveski Z et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995; 86: 1408-1419
12. De Caestecker MP, Telfer BA, Hutchinson IV. The detection of intracytoplasmic interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor alpha expression in human monocytes using two colour immunofluorescence flow cytometry. J Immunol Methods 1992; 154: 11-20
13. Pertosa G, Grandaliano G, Gesualdo L, Schena FP. Clinical relevance of cytokine production in hemodialysis. Kidney Int 2000; 58 [Suppl 76]: S104-S111
14. Sester U, Sester M, Hank M, Kaul H, Kohler H, Girndt M. T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant 2000; 15: 1217-1223
15. Daichou Y, Kurashige S, Hashimoto S, Suzuki S. Characteristics cytokine products of Th1 and Th2 cells in hemodialysis patients. Nephron 1999; 83: 237-245
16. Xie J, Wang Y, Freeman, ME, III, Barlogie B, Yi Q. β2-microglobulin as a negative regulator of the immune system: High concentrations of the protein inhibit in vitro generation of functional dendric cells. Blood 2003; 101: 4005-4012
17. Bloembergen WE, Port FK. Epidemiological perspective on infections in chronic dialysis patients. Adv Renal Replacement Ther 1996; 3: 201-207
18. Bennett-Jones DN, Yewdall VMA, Gillespie CME, Ogg CS, Cameron JS. Strain differences in the opsonisation of staphylococcus epidermidis. Perit Dial Int 1989; 9: 333-339